ramelteon: Clinical Trials

76 trials of ramelteon, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

49 completed, 13 terminated, 7 unknown, 5 withdrawn. 31 Phase 4, 19 Phase 3, 14 Phase 2, 7 Not applicable, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 431Completed 19, Terminated 4, Unknown 4, Withdrawn 3, Not yet recruiting 1
Phase 319Completed 11, Terminated 5, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 214Completed 12, Terminated 1, Unknown 1
Not applicable7Terminated 3, Completed 2, Unknown 1, Withdrawn 1
Phase 13Completed 3

Follow ramelteon: new trials by email Literature Review of ramelteon trials Research Report on ramelteon

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Doxepin Alone or Combined With Ramelteon Versus Placebo for Improving Sleep Quality After Primary Total Knee Arthroplasty
Doxepin 6 mg, Ramelteon 8 mg, Placebo Tablets - Sleep Quality Post-TKA, Postoperative Knee Function
Phase 4Not yet recruitingUniversity of Washington1292026-06-012026-05-20
A Study of Ramelteon in Chinese Patients With Chronic Insomnia
Ramelteon, Ramelteon placebo - Chronic Insomnia
Phase 3Not yet recruitingNanjing Chia-tai Tianqing Pharmaceutical2802024-08-012024-07-22
Melatonin Agonist for Shift-time Workers.
Ramelteon - Circadian Rhythm Disorders
Phase 4CompletedTri-Service General Hospital (TSGH)612024-03-042026-02-03
Delirium Reduction With Ramelteon
Ramelteon 8mg - Delirium
Phase 4UnknownCentennial Medical Center5062023-03-262024-08-22
Insomnia Prevalence and Treatment Impact on Systemic Hypertension
Ramelteon (RozeremR), sleep hygiene - Insomnia, Hypertension
Phase 4TerminatedUniversity of Sao Paulo52022-05-012022-12-29
Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19
Ramelteon 8mg - Covid19, Lung Injury
Phase 2UnknownAssociação Fundo de Incentivo à Pesquisa1002020-09-012020-07-24
Ramelteon vs Placebo for Prevention of Delirium and Improvement of Sleep in Hospitalized Older Adults
Ramelteon, Placebo - Delirium in Old Age
Phase 4WithdrawnBrigham and Women's Hospital2019-12-012020-01-22
The Effect of Ramelteon on Delirium and Sleep in Patients Admitted to the ICU
Ramelteon, Placebo - Cap - Delirium
Phase 4CompletedRhode Island Hospital1122019-05-092024-04-10
The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia
Ramelteon 8mg, Placebo - Chronic Insomnia
Phase 4CompletedTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan172018-02-062024-11-20
Ramelteon for Complex Insomnia in Veterans With PTSD
Ramelteon, Usual Care - Insomnia
Phase 4WithdrawnState University of New York at Buffalo2018-01-012021-04-09
The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy
Ramelteon - Insomnia, Major Depressive Disorder
Phase 4CompletedTakeda262017-05-092019-07-22
Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia
Risperidone, Risperidone and Ramelteon, Haloperidol - Schizophrenia
Phase 4CompletedAll India Institute of Medical Sciences, Bhubaneswar1202017-05-012019-05-03
Ramelteon in the Prevention of Post-operative Delirium
Ramelteon, Microcrystalline Cellulose, Riboflavin 100 mg - Delirium, Delirium, Dementia, Amnestic, Cognitive Disorders
Phase 2CompletedJohns Hopkins University802017-03-242020-06-30
Ramelteon Prevention of Delirium - RCT
ramelteon, Placebo - Delirium
Phase 4UnknownHartford Hospital2402017-02-232018-08-01
Ramelteon for Treatment of Insomnia in Cirrhosis
Ramelteon Pill - Cirrhosis
Phase 4CompletedVirginia Commonwealth University102017-02-012021-03-29
Ramelteon and Citicoline for Delirium
Ramelteon, Citicoline - Delirium
Phase 4WithdrawnUniversity of Texas Southwestern Medical Center2016-07-012017-11-09
The Impact of Ramelteon on Sleep and Delirium in Patients Who Undergo Pulmonary Thromboendarterectomy (PTE) Surgery
Ramelteon, Placebo - Delirium, Sleep Deprivation
Not applicableUnknownUniversity of California, San Diego1202016-02-012022-02-08
Effect of Ramelteon on Smoking Abstinence
Ramelteon, Placebo - Tobacco Use Disorder
Phase 2CompletedUniversity of Pennsylvania1402015-09-012019-11-04
A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 Disorder
Ramelteon SL (Dose 1), Ramelteon SL (Dose 2), Placebo - Bipolar Disorder
Phase 3WithdrawnTakeda2012-09-012013-01-23
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder
Ramelteon, Placebo - Bipolar Disorder
Phase 3TerminatedTakeda5352012-08-012016-03-16

Showing 20 of 76. Sign in to see all of them.

Conditions studied

Sleep Initiation and Maintenance Disorders (43)  ·  Sleep Wake Disorders (9)  ·  Delirium (7)  ·  Bipolar Disorder (4)  ·  Sleep Disorders, Intrinsic (4)  ·  Chronobiology Disorders (3)  ·  Parasomnias (3)  ·  Parkinson Disease (3)  ·  Sleep Apnea, Obstructive (3)  ·  Depressive Disorder, Major (2)  ·  Lewy Body Disease (2)  ·  Migraine Disorders (2)  ·  Parkinsonian Disorders (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  REM Sleep Behavior Disorder (2)

Sponsors

Takeda (31)  ·  Massachusetts General Hospital (3)  ·  Brigham and Women's Hospital (2)  ·  Johns Hopkins University (2)  ·  Lehigh Valley Hospital (2)  ·  Northwestern University (2)  ·  Southern California Institute for Research and Education (2)  ·  University of Pennsylvania (2)  ·  University of Texas Southwestern Medical Center (2)  ·  Accelerated Community Oncology Research Network (1)  ·  All India Institute of Medical Sciences, Bhubaneswar (1)  ·  Associação Fundo de Incentivo à Pesquisa (1)  ·  Centennial Medical Center (1)  ·  Charlottesville Neuroscience (1)  ·  Duke University (1)

Countries

United States (56)  ·  Japan (3)  ·  Czechia (2)  ·  Germany (2)  ·  Russia (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Finland (1)  ·  France (1)  ·  India (1)  ·  Italy (1)

Top investigators

Edward R. Norris, MD (2)  ·  Aleksandar Videnovic, M.D. (1)  ·  Ali El Solh, MD (1)  ·  Andrew Krystal, MD (1)  ·  Andrius Baskys, M.D. (1)  ·  Anthony Lequerica, PhD (1)  ·  Brandon S Lu, MD, MS (1)  ·  Catherine S. Sassoon, MD (1)  ·  Chin-Bin Yeh, M.D., Ph.D. (1)  ·  Dalva Poyares, PhD (1)

Results publications

PMID 19327100, PMID 17015817, PMID 11559786, PMID 14735295, PMID 15683149, PMID 16185814, PMID 16709464, PMID 17294232, PMID 17335321, PMID 17519067, PMID 17803013, PMID 17996657, PMID 18584227, PMID 18627623, PMID 18691937, PMID 18691991, PMID 18840034, PMID 18853704, PMID 19090503, PMID 19228178, PMID 19284927, PMID 19294955, PMID 19317379, PMID 1950621, PMID 20483660, PMID 20861739, PMID 21206545, PMID 21296508, PMID 21359104, PMID 21966064, PMID 21975110, PMID 22122006, PMID 22194182, PMID 22963894, PMID 24090266, PMID 25887111, PMID 25956235, PMID 2748771, PMID 31567351, PMID 32532654, PMID 33189083, PMID 3616518, PMID 36702822, PMID 3757924, PMID 8791041, PMID 9396013, PMID 9406042

NIH funding

2004 (2), R01AG028769 (1), R01DK087913 (1), R21AG050850 (1), R21DA025794 (1), R21DA040902 (1)